Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Oz 277
2. Oz-277
3. Oz277 Cpd
4. Rbx 11160
5. Rbx-11160
1. 664338-39-0
2. Arterolane [inn]
3. Oz 277
4. Rbx11160
5. Oz277
6. Oz-277
7. Rbx-11160
8. 3n1tn351vb
9. Rbx 11160
10. Oz 277;rbx 11160
11. N-(2-amino-2-methylpropyl)-2-{dispiro[adamantane-2,2'-[1,3,5]trioxolane-4',1''-cyclohexane]-4''-yl}acetamide
12. Arterolano
13. Arterolanum
14. Unii-3n1tn351vb
15. Oz277 Cpd
16. Arterolane [who-dd]
17. Chembl221773
18. Chembl404431
19. Chembl578577
20. Chembl580910
21. Schembl4547841
22. Chembl1197433
23. Schembl10307589
24. Schembl11379522
25. Schembl12612733
26. Schembl13951812
27. Dtxsid50985095
28. Chebi:136054
29. Zinc14191464
30. At25294
31. Ncgc00274173-01
32. Hy-10852
33. Cs-0002648
34. Dispiro(cyclohexane-1,3'-(1,2,4)trioxolane-5',2''-tricyclo(3.3.1.13,7)decane)-4-acetamide, N-(2-amino-2-methylpropyl)-, Cis-
35. N-(2-amino-2-methylpropyl)-2-((1r,3r,4''s,5r,5's,7r)-dispiro[adamantane-2,3'-[1,2,4]trioxolane-5',1''-cyclohexan]-4''-yl)acetamide
36. N-(2-amino-2-methylpropyl)-2-[(1s,4s)-dispiro[cyclohexane-1,3'-[1,2,4]trioxolane-5',2''-tricyclo[3.3.1.1(3,7)]decan]-4-yl]acetamide
Molecular Weight | 392.5 g/mol |
---|---|
Molecular Formula | C22H36N2O4 |
XLogP3 | 2.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 392.26750763 g/mol |
Monoisotopic Mass | 392.26750763 g/mol |
Topological Polar Surface Area | 82.8 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 598 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
Reply
08 Jul 2022
ABOUT THIS PAGE
A Arterolane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Arterolane, including repackagers and relabelers. The FDA regulates Arterolane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Arterolane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Arterolane supplier is an individual or a company that provides Arterolane active pharmaceutical ingredient (API) or Arterolane finished formulations upon request. The Arterolane suppliers may include Arterolane API manufacturers, exporters, distributors and traders.
Arterolane Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Arterolane GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Arterolane GMP manufacturer or Arterolane GMP API supplier for your needs.
A Arterolane CoA (Certificate of Analysis) is a formal document that attests to Arterolane's compliance with Arterolane specifications and serves as a tool for batch-level quality control.
Arterolane CoA mostly includes findings from lab analyses of a specific batch. For each Arterolane CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Arterolane may be tested according to a variety of international standards, such as European Pharmacopoeia (Arterolane EP), Arterolane JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Arterolane USP).
LOOKING FOR A SUPPLIER?